Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1989 3
1990 3
1991 4
1992 3
1993 1
1994 6
1995 9
1996 2
1997 4
1998 5
1999 5
2000 4
2001 8
2002 5
2003 5
2004 5
2005 10
2006 7
2007 4
2008 6
2009 10
2010 9
2011 11
2012 5
2013 10
2014 6
2015 12
2016 8
2017 11
2018 11
2019 8
2020 16
2021 11
Text availability
Article attribute
Article type
Publication date

Search Results

207 results
Results by year
Filters applied: . Clear all
Page 1
The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Midgut Neuroendocrine Tumors.
Strosberg JR, Halfdanarson TR, Bellizzi AM, Chan JA, Dillon JS, Heaney AP, Kunz PL, O'Dorisio TM, Salem R, Segelov E, Howe JR, Pommier RF, Brendtro K, Bashir MA, Singh S, Soulen MC, Tang L, Zacks JS, Yao JC, Bergsland EK. Strosberg JR, et al. Among authors: soulen mc. Pancreas. 2017 Jul;46(6):707-714. doi: 10.1097/MPA.0000000000000850. Pancreas. 2017. PMID: 28609356 Free PMC article. Review.
Activity of Mesothelin-Specific Chimeric Antigen Receptor T Cells Against Pancreatic Carcinoma Metastases in a Phase 1 Trial.
Beatty GL, O'Hara MH, Lacey SF, Torigian DA, Nazimuddin F, Chen F, Kulikovskaya IM, Soulen MC, McGarvey M, Nelson AM, Gladney WL, Levine BL, Melenhorst JJ, Plesa G, June CH. Beatty GL, et al. Among authors: soulen mc. Gastroenterology. 2018 Jul;155(1):29-32. doi: 10.1053/j.gastro.2018.03.029. Epub 2018 Mar 20. Gastroenterology. 2018. PMID: 29567081 Free PMC article. Clinical Trial.
Phase I Study of Lentiviral-Transduced Chimeric Antigen Receptor-Modified T Cells Recognizing Mesothelin in Advanced Solid Cancers.
Haas AR, Tanyi JL, O'Hara MH, Gladney WL, Lacey SF, Torigian DA, Soulen MC, Tian L, McGarvey M, Nelson AM, Farabaugh CS, Moon E, Levine BL, Melenhorst JJ, Plesa G, June CH, Albelda SM, Beatty GL. Haas AR, et al. Among authors: soulen mc. Mol Ther. 2019 Nov 6;27(11):1919-1929. doi: 10.1016/j.ymthe.2019.07.015. Epub 2019 Jul 30. Mol Ther. 2019. PMID: 31420241 Free PMC article. Clinical Trial.
Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update.
Ahmed M, Solbiati L, Brace CL, Breen DJ, Callstrom MR, Charboneau JW, Chen MH, Choi BI, de Baère T, Dodd GD 3rd, Dupuy DE, Gervais DA, Gianfelice D, Gillams AR, Lee FT Jr, Leen E, Lencioni R, Littrup PJ, Livraghi T, Lu DS, McGahan JP, Meloni MF, Nikolic B, Pereira PL, Liang P, Rhim H, Rose SC, Salem R, Sofocleous CT, Solomon SB, Soulen MC, Tanaka M, Vogl TJ, Wood BJ, Goldberg SN; International Working Group on Image-guided Tumor Ablation; Interventional Oncology Sans Frontières Expert Panel; Technology Assessment Committee of the Society of Interventional Radiology,; Standard of Practice Committee of the Cardiovascular and Interventional Radiological Society of Europe. Ahmed M, et al. Among authors: soulen mc. Radiology. 2014 Oct;273(1):241-60. doi: 10.1148/radiol.14132958. Epub 2014 Jun 13. Radiology. 2014. PMID: 24927329 Free PMC article.
Appropriate Use Criteria for Somatostatin Receptor PET Imaging in Neuroendocrine Tumors.
Hope TA, Bergsland EK, Bozkurt MF, Graham M, Heaney AP, Herrmann K, Howe JR, Kulke MH, Kunz PL, Mailman J, May L, Metz DC, Millo C, O'Dorisio S, Reidy-Lagunes DL, Soulen MC, Strosberg JR. Hope TA, et al. Among authors: soulen mc. J Nucl Med. 2018 Jan;59(1):66-74. doi: 10.2967/jnumed.117.202275. Epub 2017 Oct 12. J Nucl Med. 2018. PMID: 29025982 Free PMC article. No abstract available.
Deep Learning to Distinguish Benign from Malignant Renal Lesions Based on Routine MR Imaging.
Xi IL, Zhao Y, Wang R, Chang M, Purkayastha S, Chang K, Huang RY, Silva AC, Vallières M, Habibollahi P, Fan Y, Zou B, Gade TP, Zhang PJ, Soulen MC, Zhang Z, Bai HX, Stavropoulos SW. Xi IL, et al. Among authors: soulen mc. Clin Cancer Res. 2020 Apr 15;26(8):1944-1952. doi: 10.1158/1078-0432.CCR-19-0374. Epub 2020 Jan 14. Clin Cancer Res. 2020. PMID: 31937619
Interventional Oncology Approach to Hepatic Metastases.
O'Leary C, Soulen MC, Shamimi-Noori S. O'Leary C, et al. Among authors: soulen mc. Semin Intervent Radiol. 2020 Dec;37(5):484-491. doi: 10.1055/s-0040-1719189. Epub 2020 Dec 11. Semin Intervent Radiol. 2020. PMID: 33328704 Review.
207 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page